Contact us for free information or to start a free case review.
The source of a number of recent Neurontin lawsuits has been the revelation that drug''s manufacturers illegally marketed Neurontin for non-FDA approved uses, and paid physicians tens of thousands of dollars to recommend the drug based on faulty drug trial results. In recent disclosures related to Neurontin lawsuits, current drug manufacturer Pfizer has admitted that non-approved uses account for around 80% of Neurontin prescriptions.
Many Neurontin lawsuits were filed on behalf of patients who were prescribed Neurontin for conditions such as bipolar disorder, drug and alcohol withdrawal, attention deficit disorder, and other conditions for which the FDA had not approved the use of Neurontin. Neurontin lawsuits may also be filed if patients suffered from Neurontin side effects, especially if they were not sufficiently advised of such complications.
Claimants in Neurontin lawsuits will often seek to recover the cost of medication, any medical costs stemming from the damage done by the drug, pain and suffering, and in some cases, punitive damages against the defendant. You may wish to join a Neurontin lawsuit if you or a loved one has suffered due to Neurontin that was prescribed for a non-FDA approved use, or has experienced side effects as a result of taking the drug,. To find out more about Neurontin lawsuits and to learn about your legal options, contact an attorney who is experienced in working with Neurontin lawsuit candidates.
The FDA has requested 14 drugmakers to check their study data to see if use of epilepsy drugs results in suicidal behavior or thoughts, giving the drugmakers six months to respond.
Sales of anti-seizure drugs in the U.S. during 2004 were th...
Just weeks after Pfizer and its Warner-Lambert Co. unit were penalized $430 million in federal and state courts for selling Neurontin for purposes that have not yet been FDA approved, the company is again under fire for fraudulent marketing practices. ...
The world''s largest drug manufacturer, Pfizer, Inc., agreed to pay at least $400 million in order to settle civil charges regarding kickbacks to encourage doctors to prescribe the anti-epileptic drug Neurontin for other purposes.
The se...
Copyright © 2001 - 2012 Online Lawyer Source | Legal Marketing Site Designed by eJustice
ATTORNEY ADVERTISEMENT—Thank you for your visit. The content published on this website was not written by medical professionals and should not, at any point, be mistaken for medical advice. Furthermore, the information on this site is intended for educational purposes only and should never interfere with a patient/site visitor and his or her healthcare provider. In addition, viewing the content on this website, requesting additional information, or transmitting information through a contact form should never be considered the formation of an attorney-client relationship. The material published on this site is general and may not apply to your specific circumstances. Every case comes with its own set of unique circumstances; past success discussed on this site does not guarantee future performance. Information found on this website should not be used as incentive to act without seeking counsel from a professional. For more information, please read our disclaimer.